Delivery Order SPE2DX15D2012-SPE2DX24F7TD2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) contract valued at $82,262.41. The contract is with the Defense Logistics Agency (DLA) and is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 15, 2022 and a firm fixed price pricing type. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $15,397.08 for the supply of STELARA 90 MG/ML SYRINGEML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 15, 2022. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $6,591.09 for the supply of STELARA 90 MG/ML syringes. The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $37,239.30 for the supply of STELARA 90 MG/ML SYRINGE to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 16, 2025 and uses a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $75,218.53 Firm Fixed Price Delivery Order for the supply of STELARA 90 MG/ML syringes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is a major customer for Amerisourcebergen's federal contracting activities. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award is held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $21,288.35 for the pharmaceutical product STELARA 90 MG/ML SYRINGE. This contract has an ultimate completion date of April 10, 2023 and is a Firm Fixed Price arrangement. The award was made without any set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an award value of $25,038.52 and is for the delivery of STELARA 90 MG/ML SYRINGEML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $8,487.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is a Firm Fixed Price Delivery Order with a completion date of May 24, 2022. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Stelara 90 mg/ml syringes. The $19,920.43 Firm Fixed Price contract was awarded on January 4, 2022 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of January 5, 2022. The contract is a Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- SPE2DX15D2012Indefinite Delivery Contract
- SPE2DX15D2012-SPE2DX24F7TD2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX15D2012|SPE2DX24F7TD2) with a ceiling value of $27,290.51. The contract is for the supply of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The award has an ultimate completion date of December 5, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively, for the delivery of a wide range of pharmaceutical products and medical supplies to support military, veteran, and federal healthcare programs. This contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 12/4/23 |